Cannara Biotech Inc (LOVE.V)
0.72
-0.02
(-2.70%)
CAD |
TSXV |
May 31, 16:00
Cannara Biotech Revenue (Quarterly): 19.68M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 19.68M |
November 30, 2023 | 19.48M |
August 31, 2023 | 18.33M |
May 31, 2023 | 15.84M |
February 28, 2023 | 13.04M |
November 30, 2022 | 10.31M |
August 31, 2022 | 12.25M |
May 31, 2022 | 9.989M |
February 28, 2022 | 7.422M |
November 30, 2021 | 6.565M |
August 31, 2021 | 6.235M |
Date | Value |
---|---|
May 31, 2021 | 7.159M |
February 28, 2021 | 2.258M |
November 30, 2020 | 1.368M |
August 31, 2020 | 0.5853M |
May 31, 2020 | 0.7639M |
February 29, 2020 | 0.6684M |
November 30, 2019 | 0.5332M |
August 31, 2019 | 0.5533M |
May 31, 2019 | 0.5068M |
February 28, 2019 | 0.5184M |
November 30, 2018 | 0.5184M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.5332M
Minimum
Nov 2019
19.68M
Maximum
Feb 2024
8.055M
Average
7.159M
Median
May 2021
Revenue (Quarterly) Benchmarks
Biocure Technology Inc | -- |
Core One Labs Inc | 0.0937M |
Nova Mentis Life Science Corp | 0.0283M |
Nanosphere Health Sciences Inc | -- |
Lobe Sciences Ltd | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -3.447M |
Total Expenses (Quarterly) | 21.64M |
EPS Diluted (Quarterly) | -0.04 |
Enterprise Value | 110.36M |
Gross Profit Margin (Quarterly) | 21.04% |
Profit Margin (Quarterly) | -17.51% |
Earnings Yield | 8.33% |
Operating Earnings Yield | 18.05% |
Normalized Earnings Yield | 8.366 |